Vanguard Group Inc Cytokinetics Inc Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
396Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$706 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$518 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$380 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$297 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$137 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.53B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...